Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by CommonCentsforDollarson Apr 06, 2021 1:11pm
150 Views
Post# 32942319

RE:Hmm...

RE:Hmm...
DumbOracle wrote: The little MarketWatch piece about the lowered earnings estimate smells funny to me. Stifel's reasoning seems pretty broad and unspecific to our company. I still say get some while you can and don't expect too many more days in the low 20s.


If they were specific they would say that they are getting buried on their short position so they are re-rating before earnings unlike professional institutions that re-rate AFTER earnings as they are looking for a window to cover their short position. The market manipulation of this sector appearingly doesn't end. Pissed at this total bs. Sorry for all longs.

<< Previous
Bullboard Posts
Next >>